Menu
Currency
GWAS Study

GWAS Identifies Two Novel Colorectal Cancer Loci at 16q24.1 and 20q13.12.

Tanikawa C, Kamatani Y, Takahashi A et al.

29471430 PubMed ID
GWAS Study Type
44916 Participants
35 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TC
Tanikawa C
KY
Kamatani Y
TA
Takahashi A
MY
Momozawa Y
LK
Leveque K
NS
Nagayama S
MK
Mimori K
MM
Mori M
IH
Ishii H
IJ
Inazawa J
YJ
Yasuda J
TA
Tsuboi A
SA
Shimizu A
SM
Sasaki M
YT
Yamaji T
SN
Sawada N
IM
Iwasaki M
TS
Tsugane S
NM
Naito M
WK
Wakai K
KT
Koyama T
TT
Takezaki T
YK
Yuji K
MY
Murakami Y
NY
Nakamura Y
KM
Kubo M
MK
Matsuda K
Chapter II

Abstract

Summary of the research findings

Colorectal cancer (CRC) is the fourth leading cause of cancer mortality worldwide. Genome-wide association studies (GWAS) identified more than 50 CRC loci. However, most of the previous studies were conducted in European population, and host genetic factors among Japanese population are largely remained to be identified. To identify novel loci in the Japanese population, here, we performed a large-scale GWAS using 6692 cases and 27 178 controls followed by a replication analysis using more than 11 000 case-control samples. We found the significant association of 10 loci (P < 5 × 10-8), including 2 novel loci on 16q24.1 (IRF8-FOXF1, rs847208, P = 3.15 × 10-9 and odds ratio = 1.107 with 95% confidence interval (CI) of 1.071-1.145) and 20q13.12 (TOX2, rs6065668, P = 4.47 × 10-11 and odds ratio = 0.897 with 95% CI of 0.868-0.926). Moreover, 35 previously reported single nucleotide polymorphisms (SNPs) in 24 regions were validated in the Japanese population (P < 0.05) with the same risk allele as in the previous studies. SNP rs6065668 was significantly associated with TOX2 expression in the sigmoid colon. In addition, nucleotide substitutions in the regulatory region of TOX2 were predicted to alter the binding of several transcription factors, including KLF5. Our findings elucidate the important role of genetic variations in the development of CRC in the Japanese population.

6,692 Japanese ancestry cases, 27,178 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

44916
Total Participants
GWAS
Study Type
Yes
Replicated
3,713 Japanese ancestry cases, 7,333 Japanese ancestry controls
Replication Participants
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.